Maternal immunization: Optimizing protection for the mother and infant
- PMID: 27233120
- DOI: 10.1016/j.jinf.2016.04.027
Maternal immunization: Optimizing protection for the mother and infant
Abstract
Immunizing the pregnant woman to protect both the mother and her infant from infection has been utilized increasingly over the last decade. New outbreaks of pandemic influenza and the resurgence of pertussis have resulted in policy changes and shifts in health authority recommendations for a number of vaccines aimed to protect both pregnant women and their infants in the first months of life. The ability of maternal immunoglobulin IgG antibodies to be transported readily across the healthy intact placenta depends on many different factors including gestational age in the pregnancy, nature and timing of the immunization and presence of maternal HIV or malaria infections. In this paper, the history of maternal immunization is described, and specifically the studies that prompted the recommendations for tetanus, influenza, pertussis, and, when needed, meningococcus vaccines in pregnant women are reviewed. Ongoing research may result in new maternal vaccines against other pathogens including respiratory syncytial virus and group B streptococcus. Both scientific and regulatory considerations remain challenging in licensure of vaccines specifically for maternal immunization.
Keywords: Influenza vaccine; Maternal immunization; Respiratory syncytial virus; Tetanus vaccine; Vaccines.
Copyright © 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Maternal immunization: where are we now and how to move forward?Ann Med. 2018 May;50(3):193-208. doi: 10.1080/07853890.2017.1421320. Epub 2018 Jan 17. Ann Med. 2018. PMID: 29308916 Review.
-
Who's the Target: Mother or Baby?Viral Immunol. 2018 Mar;31(2):184-194. doi: 10.1089/vim.2017.0135. Epub 2018 Feb 23. Viral Immunol. 2018. PMID: 29474132 Review.
-
Maternal Immunization.Obstet Gynecol. 2019 Apr;133(4):739-753. doi: 10.1097/AOG.0000000000003161. Obstet Gynecol. 2019. PMID: 30913173 Review.
-
Why Should We Advocate Maternal Immunization?Pediatr Infect Dis J. 2019 Jun;38(6S Suppl 1):S28-S32. doi: 10.1097/INF.0000000000002312. Pediatr Infect Dis J. 2019. PMID: 31205241 Free PMC article.
-
Vaccines in pregnant women and research initiatives.Clin Obstet Gynecol. 2012 Jun;55(2):474-86. doi: 10.1097/GRF.0b013e31824f3acb. Clin Obstet Gynecol. 2012. PMID: 22510631 Review.
Cited by
-
A live attenuated vaccine to prevent severe neonatal Escherichia coli K1 infections.Nat Commun. 2024 Apr 8;15(1):3021. doi: 10.1038/s41467-024-46775-x. Nat Commun. 2024. PMID: 38589401 Free PMC article.
-
Timing of Maternal COVID-19 Vaccine and Antibody Concentrations in Infants Born Preterm.JAMA Netw Open. 2024 Jan 2;7(1):e2352387. doi: 10.1001/jamanetworkopen.2023.52387. JAMA Netw Open. 2024. PMID: 38241046 Free PMC article.
-
Maternal effects drive intestinal development beginning in the embryonic period on the basis of maternal immune and microbial transfer in chickens.Microbiome. 2023 Mar 3;11(1):41. doi: 10.1186/s40168-023-01490-5. Microbiome. 2023. PMID: 36869365 Free PMC article.
-
Intermediate Levels of Pre-Existing Protective Antibody Allow Priming of Protective T Cell Immunity against Influenza.J Immunol. 2023 Mar 1;210(5):628-639. doi: 10.4049/jimmunol.2200393. J Immunol. 2023. PMID: 36645384 Free PMC article.
-
Safety, reactogenicity, and immunogenicity of a 2-dose Ebola vaccine regimen of Ad26.ZEBOV followed by MVA-BN-Filo in healthy adult pregnant women: study protocol for a phase 3 open-label randomized controlled trial.Trials. 2022 Jun 20;23(1):513. doi: 10.1186/s13063-022-06360-3. Trials. 2022. PMID: 35725488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical